Jorge Avila, MD
40.9K posts

Jorge Avila, MD
@jorgeeavila
Hematology and Medical Oncology Fellow @MontefioreNYC @EinsteinMed | Happy Husband | Ecuadorian 🇪🇨 | 🏋🏾🥑🎻
New York Katılım Şubat 2010
428 Takip Edilen1.2K Takipçiler
Jorge Avila, MD retweetledi

Oncologists everywhere excited this morning about this new era of effective targeted therapy for #pancreaticcancer with press release of positive #Daraxonrasib (panKRASi) trial
▶️Ph 3 #RASolute302 daraxonrasib 💊 vs chemo ▶️mOS of 13.2 mos vs 6.7 mos HR 0.40 (p < 0.0001). #precisionmedicine

English
Jorge Avila, MD retweetledi

TNBC is no longer a chemo disease.
This 1 algorithm shows the shift:
👉 ADCs + biomarkers are now driving frontline decisions.
🧬 Metastatic TNBC - how to think today
PD-L1 ≥10
• Pembro + chemo
• OR Pembro + SG
PD-L1 <10
• SG or Dato-DXd now competing with chemo
BRCA-mut
• PARP inhibitors
HER2-low
• T-DXd option
Later lines
• ADC sequencing
• Biomarker-directed therapy
🧠 Paradigm shift
❌ Before: one-size chemo
✅ Now: IO + ADCs + PARPi + precision oncology
⚠️ What matters next
Not just “which drug”
👉 but “what sequence”
Topo-1 ADCs → real cross-resistance concern
🎯 Takeaway
Advanced TNBC has entered the ADC era.
Smart sequencing will define outcomes. 🔖
📖 Full paper in comment ⬇️
#OncoTwitter #MedTwitter #TNBC #BreastCancer @OncoAlert @myesmo @esmo_open @JCOPO_ASCO

English

After >2 months off X, I'm back.
To be honest, it was somewhat refreshing but I do miss #medtwitter
English

Happy to share our recent publication @jesusanampa @BernabeCarolina @EinsteinMed
Adjuvant Chemotherapy Outcomes in Older Adults With Nonmetastatic Triple-Negative Breast Cancer jamanetwork.com/journals/jaman…
English
Jorge Avila, MD retweetledi

👏👏👏 to Michelle Williams in Dying for Sex! Congratulations on winning the #GoldenGlobes award for Best Female Actor – Television – Limited Series, Anthology Series or Television Motion Picture!

English
Jorge Avila, MD retweetledi

You don’t need to give up pernil, pastas, or coquito to stay healthy this season. @DrOstfeld shares easy ways to lighten traditional plates, cut back on added sugar, & swap in plants so you can enjoy Bronx holiday meals while supporting your heart health. bit.ly/3MPB5Ah

English

So true! Abstracts are a great way to start our path to academia or fellowship but there should be a limit. I’ll never forget when someone tweeted they had 12 abstracts accepted (!!!). That, to me, is a red flag. 1 or 2 should be more than enough.
Samer Al Hadidi, MD,MS,FACP@HadidiSamer
Check our viewpoint published @JAMA_current #MedEd Abstract Factory—Research Culture Harming Medical Education The "abstract factory" is destroying medical education. Trainees and junior faculty compete with abstract counts instead of meaningful research. Result: inflated CVs, diluted conferences. We shouldn't celebrate this—you don't need publications to be a great doctor. ➡️jamanetwork.com/journals/jama/… @utswcancer @rajshekharucms @HiraSMian @ManniMD1 @HemOncFellows @ASCOTECAG
English

@marincine En total desacuerdo. Fui con 0 expectativas y terminé muy conmovido. Fue lo suficientemente dramática sin rayar en lo ridículo. Mi segunda favorita del año.
Español
Me decepcionó Jay Kelly, la sobrevalorada y poco convincente película de #Netflix sobre la vida privada de una estrella de cine, interpretada por George Clooney; se queda en una mera idea, de fallida resolución, que luce postiza y gratuita y que no fluye adecuadamente.




Español

Very productive days in #SABCS25 one poster presentation, one spotlight discussion and a young investigator award. Thankful to my team and mentors for their support @MontefioreNYC




English
Jorge Avila, MD retweetledi

.@jorgeeavila reports our study on factors associated with short and long term survival in lobular breast cancer.
#sabcs25 @MontefioreNYC #bcsm @SABCSSanAntonio


San Antonio, TX 🇺🇸 English
Jorge Avila, MD retweetledi

Presented at #SABCS25:
In patients with HER2-positive early breast cancer and residual disease after neoadjuvant therapy, trastuzumab deruxtecan improved invasive disease–free survival but carried a risk of interstitial lung disease. Full DESTINY-Breast05 phase 3 trial results: nej.md/4an3Az2
@SABCSSanAntonio

English
Jorge Avila, MD retweetledi

Adding tucatinib to 1L maintenance HP led to an 8.6 month improvement in PFS in HER2+ disease in #HER2CLIMB-05.
🔹A greater PFS benefit was seen in HR- disease.
🔹No difference in CNS PFS was observed but a doubling of CNS PFS in patients with baseline brain metastases.
🔹Preliminary OS data suggests a positive trend towards benefit of the combination.




English
